首页> 外文期刊>JAMA: the Journal of the American Medical Association >Varicella disease after introduction of varicella vaccine in the United States, 1995-2000.
【24h】

Varicella disease after introduction of varicella vaccine in the United States, 1995-2000.

机译:1995-2000年在美国引进水痘疫苗后出现水痘病。

获取原文
获取原文并翻译 | 示例
           

摘要

CONTEXT: Before licensure of varicella vaccine in 1995, varicella was a universal childhood disease in the United States, causing 4 million cases, 11,000 hospitalizations, and 100 deaths every year. OBJECTIVE: To examine population-based disease surveillance data in 3 communities to document the impact of the varicella vaccination program. DESIGN, SETTING, AND SUBJECTS: Active surveillance for varicella conducted among the populations of Antelope Valley, Calif; Travis County, Tex; and West Philadelphia, Pa; from January 1, 1995, to December 31, 2000. Reporting sites included child care centers, schools, universities, physicians, public health clinics, hospitals, emergency departments, and households. MAIN OUTCOME MEASURES: Trends in number and rate of varicella cases and hospitalizations; varicella vaccine coverage. RESULTS: From 1995 through 1998, in each surveillance area, the number of verified varicella cases varied from year to year with marked springtime seasonality. In 1999, the number and rates of varicella cases and hospitalizations declined markedly. From 1995 through 2000, in Antelope Valley, Travis County, and West Philadelphia, varicella cases declined 71%, 84%, and 79%, respectively. Cases declined to the greatest extent among children aged 1 to 4 years, but cases declined in all age groups, including infants and adults. In the combined 3 surveillance areas, hospitalizations due to varicella declined from a range of 2.7 to 4.2 per 100,000 population in 1995 through 1998 to 0.6 and 1.5 per 100,000 population in 1999 and 2000, respectively (P =.15). By 2000, vaccine coverage among children aged 19 to 35 months was 82.1%, 73.6%, and 83.8% in Los Angeles County, Texas, and Philadelphia County, respectively. CONCLUSIONS: Varicella disease has declined dramatically in surveillance areas with moderate vaccine coverage. Continued implementation of existing vaccine policies should lead to further reductions of varicella disease in these communities and throughout the United States.
机译:背景:在1995年获得水痘疫苗许可之前,水痘在美国是一种普遍的儿童疾病,每年造成400万例,11,000例住院和100例死亡。目的:检查3个社区的人群疾病监测数据,以记录水痘疫苗接种计划的影响。设计,设置和主题:在加利福尼亚州羚羊谷人群中进行水痘主动监测;德克萨斯州特拉维斯县;宾夕法尼亚州西费城;从1995年1月1日到2000年12月31日。报告地点包括儿童保育中心,学校,大学,医生,公共卫生诊所,医院,急诊科和家庭。主要观察指标:水痘病例和住院的数量和比率趋势;水痘疫苗覆盖率。结果:从1995年到1998年,每个监测区域的水痘确诊病例数逐年变化,春季季节明显。 1999年,水痘病例和住院的数量和比率显着下降。从1995年到2000年,在羚羊谷,特拉维斯县和西费城,水痘病例分别下降了71%,84%和79%。在1至4岁的儿童中,病例下降的幅度最大,但在所有年龄段(包括婴儿和成人)中,病例的下降均有所下降。在合并的三个监测区域,因水痘而住院的人数从1995年到1998年的每10万人口2.7到4.2下降到1999年和2000年的每10万人口0.6和1.5(P = .15)。到2000年,洛杉矶县,得克萨斯州和费城县19至35个月大儿童的疫苗接种率分别为82.1%,73.6%和83.8%。结论:在疫苗覆盖率中等的监测地区,水痘病已大大减少。继续实施现有的疫苗政策将导致这些社区以及整个美国的水痘病进一步减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号